CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors

GlobeNewswire•January 15, 2019 The revolutionary drug delivery leader taps global finance strategist, William (Bill) Yuan, to head growing Board, which now includes prominent biotech investor, Dr. Gene Salkind OXNARD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it has appointed William (Bill) Yuan to…